GlassScriptPhysician profile
Christopher S Arroyo
NPI 1770567893
$1,538.79
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2021: $169 · 2022: $43.16 · 2023: $346 · 2024: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $706.25 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $225.97 | 2023-2024 | Pylarify |
| Astellas Pharma US INC | $180.64 | 2019-2022 | |
| Coloplast Corp | $153.87 | 2021-2023 | Torosa, Titan |
| Ferring Pharmaceuticals INC. | $91.09 | 2024 | Adstiladrin |
| Janssen Biotech, INC. | $67.67 | 2023 | Erleada |
| 180 Medical, INC. | $48.20 | 2024 | |
| Myriad Genetic Laboratories, INC. | $37.35 | 2023-2024 | Prolaris |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.